Phoenix has developed a range of Nerium oleander extract (NOE) based products with different compositional profiles resulting from their respective methods of manufacture. Some of the products contain oleandrin and others do not.  In each case, however, the products contain components derived from plant.

The varying compositional profiles results in products exhibiting different biological activities.  Each of the products, however, is safe and effective when used as directed. This is because the products are effective even when administered at doses that are well below toxic doses. Please refer to our information on safety and therapeutic window.

For more information on a specific product, hover over and click on the product code below.

PRODUCT

PBI-05204

 

PBI-07343

PBI-01207

PBI-01220

PBI-06150

PBI-01011

PBI-04711

TARGET USE

Cancer, Viral Infection,
Immune support, Neuroprotection, Neurodegenerative disease

Reduction of flu-like symptoms

Cancer, Viral Infection,
Immune Support, Neuroprotection, Neurodegenerative disease

Viral Infections

Viral Infections

Neuroprotection, Neurodegenerative disease

Neuroprotection, Neurodegenerative disease

DeVELOPMENT STAGE

Cancer: Phase 1 & 2 complete

 

Available for human use

Cancer: Phase 1
Available for human use 
under CUIND

Preclinical

Preclinical

Exploratory

Exploratory